PROGRESSIVE CORP. DL 1/ US7433151039 /
05/07/2024 16:10:52 | Chg. -2.0600 | Volume | Bid21:59:59 | Ask21:59:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
193.6000EUR | -1.05% | 10 Turnover: 1,936 |
-Bid Size: - | -Ask Size: - | 113.56 bill.EUR | - | - |
GlobeNewswire
25/06
argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire
24/06
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
24/06
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
24/06
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
13/06
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
12/06
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
12/06
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
11/06
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
11/06
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire
11/06
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire
10/06
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
10/06
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
07/06
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
07/06
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire
06/06
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...
GlobeNewswire
06/06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...